Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma. (2021)

First Author: Owen CN
Attributed to:  Development of a 'humanised' model for renal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.annonc.2021.03.204

PubMed Identifier: 33798657

Publication URI: http://europepmc.org/abstract/MED/33798657

Type: Journal Article/Review

Volume: 32

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 7

ISSN: 0923-7534